Physicians’ knowledge about FDA approval standards for ‘breakthrough therapy’

In a new study, researchers surveyed internists and specialists to examine their knowledge about U.S. Food and Drug Administration approval standards and perceptions of the ‘breakthrough therapy’ designation.